FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2973050708> ?p ?o ?g. }

• W2973050708 endingPage "51" @default.
• W2973050708 startingPage "45" @default.
• W2973050708 abstract "A simple, pangenotypic and effective treatment regimen for patients with a broad range of chronic hepatitis C virus (HCV) infections remains an unmet medical need. We conducted a phase 2, randomized, open study involving untreated patients with chronic HCV genotypes 1, 2, 3, or 6 infections. Patients without cirrhosis were randomly assigned in a 1:2 ratio to receive capsules of the NS5A inhibitor coblopasvir at a dose of 30 or 60 mg plus tablets of the nucleotide polymerase inhibitor sofosbuvir (400 mg) once daily for 12 weeks. Patients with cirrhosis received 60 mg coblopasvir plus sofosbuvir for 12 weeks. The primary endpoint was the sustained virologic response at 12 weeks after the end of therapy (SVR12). Of the 110 patients who were enrolled in the study, 59 were male, 62.7% had HCV genotype 1, 24.5% had genotype 2, 6.4% had genotype 3, and 6.4% had genotype 6. The average age was 45.5 years. A total of 10.9% of patients had compensated cirrhosis. The rate of SVR12 was 98.2% in the intention-to-treat (ITT). One genotype 6 patient with cirrhosis experienced virologic relapse. One genotype 2 patient without cirrhosis failed to complete the follow-up and quit the study. Serious adverse events (SAEs) were reported in 2 patients and were not related to coblopasvir and sofosbuvir. Most adverse events (AEs) did not require treatment. Coblopasvir plus sofosbuvir taken once daily for 12 weeks provided high rates of sustained virologic response (SVR) and had a good safety profile among patients with HCV genotypes 1, 2, 3, or 6 infections, including those with compensated cirrhosis." @default.
• W2973050708 created "2019-09-19" @default.
• W2973050708 creator A5006858509 @default.
• W2973050708 creator A5007024009 @default.
• W2973050708 creator A5008566878 @default.
• W2973050708 creator A5011562555 @default.
• W2973050708 creator A5017518886 @default.
• W2973050708 creator A5017759300 @default.
• W2973050708 creator A5021261473 @default.
• W2973050708 creator A5022325113 @default.
• W2973050708 creator A5025498462 @default.
• W2973050708 creator A5041812006 @default.
• W2973050708 creator A5045398469 @default.
• W2973050708 creator A5047554989 @default.
• W2973050708 creator A5052833788 @default.
• W2973050708 creator A5053448155 @default.
• W2973050708 creator A5069831074 @default.
• W2973050708 creator A5077061082 @default.
• W2973050708 creator A5090780152 @default.
• W2973050708 date "2019-10-02" @default.
• W2973050708 modified "2023-09-28" @default.
• W2973050708 title "Safety and efficacy of coblopasvir and sofosbuvir in patients with genotypes 1, 2, 3 and 6 HCV infections without or with compensated cirrhosis" @default.
• W2973050708 cites W1540216634 @default.
• W2973050708 cites W1980771473 @default.
• W2973050708 cites W2320330796 @default.
• W2973050708 cites W2342618707 @default.
• W2973050708 cites W2413062795 @default.
• W2973050708 cites W2418876362 @default.
• W2973050708 cites W2518054630 @default.
• W2973050708 cites W2578013986 @default.
• W2973050708 cites W2791557447 @default.
• W2973050708 doi "https://doi.org/10.1111/jvh.13208" @default.
• W2973050708 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31520460" @default.
• W2973050708 hasPublicationYear "2019" @default.
• W2973050708 type Work @default.
• W2973050708 sameAs 2973050708 @default.
• W2973050708 citedByCount "4" @default.
• W2973050708 countsByYear W29730507082020 @default.
• W2973050708 countsByYear W29730507082021 @default.
• W2973050708 countsByYear W29730507082023 @default.
• W2973050708 crossrefType "journal-article" @default.
• W2973050708 hasAuthorship W2973050708A5006858509 @default.
• W2973050708 hasAuthorship W2973050708A5007024009 @default.
• W2973050708 hasAuthorship W2973050708A5008566878 @default.
• W2973050708 hasAuthorship W2973050708A5011562555 @default.
• W2973050708 hasAuthorship W2973050708A5017518886 @default.
• W2973050708 hasAuthorship W2973050708A5017759300 @default.
• W2973050708 hasAuthorship W2973050708A5021261473 @default.
• W2973050708 hasAuthorship W2973050708A5022325113 @default.
• W2973050708 hasAuthorship W2973050708A5025498462 @default.
• W2973050708 hasAuthorship W2973050708A5041812006 @default.
• W2973050708 hasAuthorship W2973050708A5045398469 @default.
• W2973050708 hasAuthorship W2973050708A5047554989 @default.
• W2973050708 hasAuthorship W2973050708A5052833788 @default.
• W2973050708 hasAuthorship W2973050708A5053448155 @default.
• W2973050708 hasAuthorship W2973050708A5069831074 @default.
• W2973050708 hasAuthorship W2973050708A5077061082 @default.
• W2973050708 hasAuthorship W2973050708A5090780152 @default.
• W2973050708 hasConcept C104317684 @default.
• W2973050708 hasConcept C126322002 @default.
• W2973050708 hasConcept C135763542 @default.
• W2973050708 hasConcept C159047783 @default.
• W2973050708 hasConcept C168563851 @default.
• W2973050708 hasConcept C197934379 @default.
• W2973050708 hasConcept C203092338 @default.
• W2973050708 hasConcept C2522874641 @default.
• W2973050708 hasConcept C2776408679 @default.
• W2973050708 hasConcept C2776455275 @default.
• W2973050708 hasConcept C2777103181 @default.
• W2973050708 hasConcept C2777214474 @default.
• W2973050708 hasConcept C2778390639 @default.
• W2973050708 hasConcept C2780040827 @default.
• W2973050708 hasConcept C2781413609 @default.
• W2973050708 hasConcept C2781463415 @default.
• W2973050708 hasConcept C55493867 @default.
• W2973050708 hasConcept C71924100 @default.
• W2973050708 hasConcept C86803240 @default.
• W2973050708 hasConcept C90924648 @default.
• W2973050708 hasConceptScore W2973050708C104317684 @default.
• W2973050708 hasConceptScore W2973050708C126322002 @default.
• W2973050708 hasConceptScore W2973050708C135763542 @default.
• W2973050708 hasConceptScore W2973050708C159047783 @default.
• W2973050708 hasConceptScore W2973050708C168563851 @default.
• W2973050708 hasConceptScore W2973050708C197934379 @default.
• W2973050708 hasConceptScore W2973050708C203092338 @default.
• W2973050708 hasConceptScore W2973050708C2522874641 @default.
• W2973050708 hasConceptScore W2973050708C2776408679 @default.
• W2973050708 hasConceptScore W2973050708C2776455275 @default.
• W2973050708 hasConceptScore W2973050708C2777103181 @default.
• W2973050708 hasConceptScore W2973050708C2777214474 @default.
• W2973050708 hasConceptScore W2973050708C2778390639 @default.
• W2973050708 hasConceptScore W2973050708C2780040827 @default.
• W2973050708 hasConceptScore W2973050708C2781413609 @default.
• W2973050708 hasConceptScore W2973050708C2781463415 @default.
• W2973050708 hasConceptScore W2973050708C55493867 @default.
• W2973050708 hasConceptScore W2973050708C71924100 @default.
• W2973050708 hasConceptScore W2973050708C86803240 @default.
• W2973050708 hasConceptScore W2973050708C90924648 @default.

• next